FI954734L - Indolijohdannaiset 5HT1A ja/tai 5-HT2 ligandeina - Google Patents
Indolijohdannaiset 5HT1A ja/tai 5-HT2 ligandeina Download PDFInfo
- Publication number
- FI954734L FI954734L FI954734A FI954734A FI954734L FI 954734 L FI954734 L FI 954734L FI 954734 A FI954734 A FI 954734A FI 954734 A FI954734 A FI 954734A FI 954734 L FI954734 L FI 954734L
- Authority
- FI
- Finland
- Prior art keywords
- 5ht1a
- ligands
- indole derivatives
- indole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI930699A IT1271352B (it) | 1993-04-08 | 1993-04-08 | Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale |
| PCT/EP1994/001016 WO1994024125A1 (en) | 1993-04-08 | 1994-03-31 | Indole derivatives as 5-ht1a and/or 5-ht2 ligands |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI954734A0 FI954734A0 (fi) | 1995-10-05 |
| FI954734A7 FI954734A7 (fi) | 1995-10-05 |
| FI954734L true FI954734L (fi) | 1995-10-05 |
Family
ID=11365694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI954734A FI954734L (fi) | 1993-04-08 | 1994-03-31 | Indolijohdannaiset 5HT1A ja/tai 5-HT2 ligandeina |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5834493A (cs) |
| EP (1) | EP0694033A1 (cs) |
| JP (1) | JPH08508738A (cs) |
| CN (1) | CN1124960A (cs) |
| AU (1) | AU684276B2 (cs) |
| BG (1) | BG100040A (cs) |
| BR (1) | BR9406206A (cs) |
| CA (1) | CA2160020A1 (cs) |
| CZ (1) | CZ283398B6 (cs) |
| FI (1) | FI954734L (cs) |
| HU (1) | HUT74090A (cs) |
| IL (1) | IL109234A (cs) |
| IT (1) | IT1271352B (cs) |
| NO (1) | NO953967L (cs) |
| NZ (1) | NZ265055A (cs) |
| PL (1) | PL310995A1 (cs) |
| SG (1) | SG50507A1 (cs) |
| SK (1) | SK119795A3 (cs) |
| WO (1) | WO1994024125A1 (cs) |
| ZA (1) | ZA942383B (cs) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9420521D0 (en) * | 1994-10-12 | 1994-11-30 | Smithkline Beecham Plc | Novel compounds |
| WO1998051685A1 (en) * | 1997-05-09 | 1998-11-19 | H. Lundbeck A/S | Method of manufacturing sertindole |
| JP2002509149A (ja) | 1998-01-14 | 2002-03-26 | ザ ユーエイビー リサーチ ファウンデイション | 細菌ｎａｄシンテターゼ酵素の阻害剤の合成およびスクリーニング方法、その化合物、ならびに細菌ｎａｄシンテターゼ酵素の阻害剤を用いる細菌および微生物感染の治療方法 |
| US6861448B2 (en) * | 1998-01-14 | 2005-03-01 | Virtual Drug Development, Inc. | NAD synthetase inhibitors and uses thereof |
| US6673827B1 (en) | 1999-06-29 | 2004-01-06 | The Uab Research Foundation | Methods of treating fungal infections with inhibitors of NAD synthetase enzyme |
| US6133287A (en) * | 1998-03-24 | 2000-10-17 | Allelix Biopharmaceuticals Inc. | Piperidine-indole compounds having 5-HT6 affinity |
| JP2002510676A (ja) * | 1998-04-08 | 2002-04-09 | アメリカン・ホーム・プロダクツ・コーポレイション | うつ病治療用のｎ−アリールオキシエチルアミン誘導体 |
| JP2002513018A (ja) * | 1998-04-29 | 2002-05-08 | アメリカン・ホーム・プロダクツ・コーポレイション | セロトニン作動薬 |
| FR2799463B1 (fr) * | 1999-10-12 | 2004-04-16 | Adir | Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent |
| DE19951360A1 (de) * | 1999-10-26 | 2001-05-03 | Aventis Pharma Gmbh | Substituierte Indole |
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| MXPA03005433A (es) | 2000-12-22 | 2003-09-10 | Wyeth Corp | Compuestos de heterociclilalquilindol o-azaindol como ligandos de 5-hidroxitriptamina-6. |
| US7135479B2 (en) | 2002-09-12 | 2006-11-14 | Wyeth | Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans |
| KR101868165B1 (ko) * | 2010-04-22 | 2018-07-19 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
| WO2013155504A1 (en) | 2012-04-14 | 2013-10-17 | Intra-Cellular Therapies, Inc. | Novel methods |
| WO2014145192A1 (en) | 2013-03-15 | 2014-09-18 | Intra-Cellular Therapies, Inc. | Organic compounds |
| CN105939712A (zh) | 2013-12-03 | 2016-09-14 | 细胞内治疗公司 | 新方法 |
| US9745300B2 (en) | 2014-04-04 | 2017-08-29 | Intra-Cellular Therapies, Inc. | Organic compounds |
| KR20170012210A (ko) | 2014-04-04 | 2017-02-02 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
| EP3331530A4 (en) * | 2015-08-03 | 2018-12-19 | Raze Therapeutics Inc. | Mthfd2 inhibitors and uses thereof |
| KR20240170975A (ko) | 2016-01-26 | 2024-12-05 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
| ES2879888T3 (es) | 2016-03-25 | 2021-11-23 | Intra Cellular Therapies Inc | Compuestos orgánicos y su uso en el tratamiento o prevención de trastornos del sistema nervioso central |
| EP3436083A4 (en) | 2016-03-28 | 2019-11-27 | Intra-Cellular Therapies, Inc. | NOVEL COMPOSITIONS AND METHOD |
| EP3525763B1 (en) | 2016-10-12 | 2025-03-05 | Intra-Cellular Therapies, Inc. | Amorphous solid dispersions |
| US10906906B2 (en) | 2016-12-29 | 2021-02-02 | Intra-Cellular Therapies, Inc. | Organic compounds |
| WO2018126140A1 (en) | 2016-12-29 | 2018-07-05 | Intra-Cellular Therapies, Inc. | Organic compounds |
| IL268970B2 (en) | 2017-03-24 | 2023-12-01 | Intra Cellular Therapies Inc | Oral preparations of heterocyclic gamma carboline derivatives fused for absorption through mucous membranes |
| CA3071119A1 (en) | 2017-07-26 | 2019-01-31 | Intra-Cellular Therapies, Inc. | Substituted heterocycle fused gamma-carbolines for treatment or prophylaxis of central nervous system disorders |
| CN111093664B (zh) | 2017-07-26 | 2023-06-02 | 细胞内治疗公司 | 有机化合物 |
| WO2019183341A1 (en) | 2018-03-23 | 2019-09-26 | Intra-Cellular Therapies, Inc. | Organic compounds |
| EP3801527B1 (en) | 2018-06-08 | 2025-02-19 | Intra-Cellular Therapies, Inc. | Fused gamma-carbolines for acute treatment of anxiety or depression |
| US12144808B2 (en) | 2018-08-29 | 2024-11-19 | Intra-Cellular Therapies, Inc. | Compositions and methods |
| KR20210052472A (ko) | 2018-08-31 | 2021-05-10 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 신규한 방법 |
| CA3108553A1 (en) | 2018-08-31 | 2020-03-05 | Intra-Cellular Therapies, Inc. | Novel methods |
| CN114072150A (zh) | 2019-07-07 | 2022-02-18 | 细胞内治疗公司 | 新方法 |
| US12414948B2 (en) | 2022-05-18 | 2025-09-16 | Intra-Cellular Therapies, Inc. | Methods |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0429341A3 (en) * | 1989-11-20 | 1991-11-13 | Rhone-Poulenc Sante | Heterocyclic derivatives, their preparation and pharmaceuticals containing them |
| RO111767B1 (ro) * | 1990-10-15 | 1997-01-30 | Pfizer | Derivati de indol, procedee si intermediari pentru prepararea acestora, compozitii farmaceutice si metoda pentru tratarea unor afectiuni |
| JP3140155B2 (ja) * | 1992-03-09 | 2001-03-05 | 杏林製薬株式会社 | Ｎ，ｎ’−ジ置換アミド誘導体 |
| TW226019B (cs) * | 1992-03-23 | 1994-07-01 | Sankyo Co |
-
1993
- 1993-04-08 IT ITMI930699A patent/IT1271352B/it active IP Right Grant
-
1994
- 1994-03-31 PL PL94310995A patent/PL310995A1/xx unknown
- 1994-03-31 CZ CZ952602A patent/CZ283398B6/cs unknown
- 1994-03-31 BR BR9406206A patent/BR9406206A/pt not_active Application Discontinuation
- 1994-03-31 SK SK1197-95A patent/SK119795A3/sk unknown
- 1994-03-31 JP JP6522684A patent/JPH08508738A/ja active Pending
- 1994-03-31 EP EP94913101A patent/EP0694033A1/en not_active Withdrawn
- 1994-03-31 NZ NZ265055A patent/NZ265055A/en unknown
- 1994-03-31 US US08/530,354 patent/US5834493A/en not_active Expired - Fee Related
- 1994-03-31 CA CA002160020A patent/CA2160020A1/en not_active Abandoned
- 1994-03-31 CN CN94192345A patent/CN1124960A/zh active Pending
- 1994-03-31 HU HU9502913A patent/HUT74090A/hu unknown
- 1994-03-31 WO PCT/EP1994/001016 patent/WO1994024125A1/en not_active Application Discontinuation
- 1994-03-31 FI FI954734A patent/FI954734L/fi unknown
- 1994-03-31 AU AU65382/94A patent/AU684276B2/en not_active Ceased
- 1994-03-31 SG SG1996002949A patent/SG50507A1/en unknown
- 1994-04-06 IL IL109234A patent/IL109234A/en not_active IP Right Cessation
- 1994-04-07 ZA ZA942383A patent/ZA942383B/xx unknown
-
1995
- 1995-10-02 BG BG100040A patent/BG100040A/bg unknown
- 1995-10-05 NO NO953967A patent/NO953967L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ265055A (en) | 1996-09-25 |
| BR9406206A (pt) | 1996-02-06 |
| EP0694033A1 (en) | 1996-01-31 |
| BG100040A (bg) | 1996-03-29 |
| AU6538294A (en) | 1994-11-08 |
| IT1271352B (it) | 1997-05-27 |
| HU9502913D0 (en) | 1995-11-28 |
| CN1124960A (zh) | 1996-06-19 |
| ITMI930699A1 (it) | 1994-10-08 |
| CZ283398B6 (cs) | 1998-04-15 |
| FI954734A0 (fi) | 1995-10-05 |
| ZA942383B (en) | 1995-10-09 |
| WO1994024125A1 (en) | 1994-10-27 |
| NO953967L (no) | 1995-12-05 |
| CA2160020A1 (en) | 1994-10-27 |
| FI954734A7 (fi) | 1995-10-05 |
| NO953967D0 (no) | 1995-10-05 |
| IL109234A (en) | 1998-04-05 |
| JPH08508738A (ja) | 1996-09-17 |
| SK119795A3 (en) | 1996-04-03 |
| ITMI930699A0 (it) | 1993-04-08 |
| IL109234A0 (en) | 1994-07-31 |
| AU684276B2 (en) | 1997-12-11 |
| CZ260295A3 (en) | 1996-01-17 |
| HUT74090A (en) | 1996-11-28 |
| US5834493A (en) | 1998-11-10 |
| PL310995A1 (en) | 1996-01-22 |
| SG50507A1 (en) | 1998-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI954734L (fi) | Indolijohdannaiset 5HT1A ja/tai 5-HT2 ligandeina | |
| FI944969A7 (fi) | Indolijohdannaisia | |
| DK43193A (da) | Indolderivater | |
| FI960840A7 (fi) | Indolijohdannaisia tromboksaani-A2-antagonisteina | |
| NO961475L (no) | Indol-derivater | |
| FI945555L (fi) | Substituoituja oksindoleja | |
| FI942395A7 (fi) | Indolijohdannaiset | |
| FI944805A0 (fi) | Indolijohdannaisia 5-HT1-kaltaisina agonisteina | |
| FI931558A7 (fi) | Indolin johdannaisia | |
| FI945674A7 (fi) | Substituoidut 2beta-morfoliini-androstaanijohdannaiset | |
| DE69212058D1 (de) | Indol-Derivate | |
| NO308236B1 (no) | Farmasøytisk blanding inneholdende indolderivater | |
| FI955164A0 (fi) | Heterosykliset johdannaiset | |
| BR9408029A (pt) | Derivados de 3-azabicicloalcanos N-substituídos | |
| FI925774A7 (fi) | Indolijohdannaiset | |
| FI960730A7 (fi) | Indolijohdannaiset 5alfa-reduktaasi-1-inhibiittoreina | |
| DK0725061T3 (da) | Substituerede indolderivater | |
| ITMI941191A0 (it) | 1-b-metil-2-tiol carbapen derivati | |
| FI955933L (fi) | Abeo-ergoliinijohdannaiset 5HT1A-ligandeina | |
| NO934473L (no) | N-substituerte azabicykloheptanderivater | |
| DE59605373D1 (de) | Substituierte Indol-Derivate | |
| ITMI930473A1 (it) | Derivati idantoinici |